Next, to examine the effects of silencing WT-BRCA1, by siRNA for BRCA1, on TGF-β mediated effects, MCF-7 breast cancer cells were either treated with si-GFP or siBRCA1. The gene discussed is TGFB1; the disease is breast carcinoma.